Humanin
Also called HN, HNG
No single human route established in this referenceAnimal / laboratory reference
Research reference
Animal / laboratory study
Original Humanin neuronal-cell experiments
Cell expression and peptide experiments—not human administration
Cell-survival assay windows
Hashimoto et al., PNAS (2001) ↗When results may show
Humanin
Evidence gap- When change was measured
- A cell-rescue effect is not a human memory or lifespan outcome; human origin of the sequence does not make the experiment a human dosing trial.
- When to assess
- Cell-survival assay windows
- Conditions and limitations
- Cultured neuronal cells with Alzheimer-related insults. No human starting amount, course length, cycling, mixing volume or time-to-result is established by this experiment. Modified Humanin analogues are separate materials.
- When to stop
- The measured study window is not a validated personal quit rule. Do not increase or prolong exposure because an expected result is absent; severe or persistent reactions need prompt clinical review.
Sources: Hashimoto et al., PNAS (2001)
Research timing is descriptive, not a promise or personal instruction. A severe or persistent reaction needs prompt clinical review. This is not medical advice.
Modelled level — 3x per week
1× is the peak after a single dose.
- Steady-state peak
- 1.00× single dose
- Time to steady state
- 3hours
- Administrations
- 3/ week
Read off the modelled curve, not an even-interval formula
About five half-lives
Where these numbers come from
- Hashimoto et al., PNAS (2001)No human starting amount, course length, cycling, mixing volume or time-to-result is established by this experiment. Modified Humanin analogues are separate materials.